Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of this integration [3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - The complaint alleges that Neogen's management issued materially false and misleading statements, leading investors to believe that the integration was progressing better than it actually was [3]. - Even after acknowledging certain "inefficiencies" from the integration, the company downplayed these issues and assured investors of their commitment to resolving them quickly [3]. Group 2: Shareholder Information - Shareholders who purchased NEOG shares during the class period are encouraged to register for the class action, with a deadline of September 16, 2025, to seek lead plaintiff status [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Clover platform and its impact on merchant business [1][3]. Allegations - The complaint alleges that Fiserv forced Payeezy merchants to convert to its Clover platform due to issues with the older Payeezy platform [3]. - Clover's revenue growth was temporarily inflated by these conversions, masking a slowdown in new merchant acquisitions [3]. - A significant number of former Payeezy merchants switched to competitors due to Clover's high pricing and inadequate customer service [3]. - As a result, Clover's GPV growth slowed significantly, and its revenue growth became unsustainable [3]. - Fiserv's positive statements regarding Clover's growth strategies and business prospects were deemed materially false and misleading [3]. Class Action Details - The class period for the lawsuit is from July 24, 2024, to July 22, 2025 [3]. - Shareholders are encouraged to register for the class action by September 22, 2025, to participate in potential recovery [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [2]. Group 1: Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [2]. - Shareholders who purchased shares during this period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of September 16, 2025 [3]. - The Gross Law Firm is facilitating the registration process and will provide portfolio monitoring software for status updates throughout the case [3]. Group 2: Allegations Against Neogen Corporation - The complaint alleges that Neogen Corporation downplayed inefficiencies arising from the integration with 3M and assured investors of their commitment to resolving these issues quickly [2]. - The misleading statements led to an artificial inflation of Neogen's stock, impacting investors who suffered losses as a result [4]. Group 3: Legal Representation - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Biohaven Ltd. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's product candidates [1][3]. Group 1: Class Action Details - The class period for the lawsuit is from March 24, 2023, to May 14, 2025 [3]. - Allegations include that Biohaven overstated the regulatory prospects of its product candidate, troriluzole, and the efficacy of BHV-7000 for bipolar disorder [3]. - The lawsuit claims that the misleading statements are likely to have a significant negative impact on Biohaven's business and financial condition [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of September 12, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

DEADLINE: October 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/kindercare-learning-companies-inc-loss-submission- form/?id=162508&from=4 NEW YORK, Aug. 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of KinderCare Learning Companies, Inc. (NYSE: KLC). Shareholders who purchased shares of KLC during the class period listed are encouraged to contact the firm regardi ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Capricor Therapeutics, Inc. regarding a potential class action lawsuit due to misleading statements related to the company's lead drug candidate, deramiocel, and its FDA approval process [1][2]. Group 1: Allegations and Impact - Shareholders who purchased shares of Capricor during the class period from October 9, 2024, to July 10, 2025, are encouraged to contact the firm for possible lead plaintiff appointment [1]. - The complaint alleges that Capricor provided investors with misleading information about deramiocel's ability to secure a Biologics License Application (BLA) from the FDA while concealing adverse facts regarding its safety and efficacy data from the Phase 2 HOPE-2 trial [1]. - Following the announcement of a Complete Response Letter (CRL) from the FDA on July 11, 2025, which denied the BLA due to insufficient evidence of effectiveness, Capricor's stock price fell from $11.40 to $7.64 per share [1]. Group 2: Next Steps for Shareholders - The deadline for shareholders to register for the class action is September 15, 2025, and they will be enrolled in a portfolio monitoring software for updates on the case [2]. - Participation in the case does not incur any cost or obligation for shareholders [2]. Group 3: Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Altimmune, Inc. faced significant stock price decline following the announcement of disappointing results from its IMPACT Phase 2b MASH trial of Pemvidutide, which failed to achieve statistical significance in its primary endpoint analysis [1][2]. Group 1: Company Performance - The IMPACT Phase 2b MASH trial results were released on June 26, 2025, revealing that while there was a positive trend in fibrosis improvement, the results did not meet statistical significance due to a higher-than-expected placebo response [1]. - Following the announcement, Altimmune's stock price plummeted from $7.71 per share on June 25, 2025, to $3.61 per share on June 26, 2025, marking a dramatic decline of 53.2% in just one day [1]. Group 2: Legal Actions - Shareholders who purchased shares of Altimmune during the class period from August 10, 2023, to June 25, 2025, are encouraged to contact the Gross Law Firm regarding potential lead plaintiff appointments in a class action lawsuit [1][2]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is October 6, 2025 [2]. Group 3: Firm's Commitment - The Gross Law Firm is dedicated to protecting the rights of investors affected by deceitful practices and aims to ensure companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that led to artificial inflation of stock prices [3].

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and deceptive practices related to the promotion of illegitimate products, which may jeopardize its collaboration with Novo Nordisk [3][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as April 29, 2025, to June 23, 2025 [3]. - Allegations include that Hims engaged in deceptive promotion and selling of knockoff versions of Wegovy®, risking patient safety [3]. - The lawsuit claims that the company's positive statements about its business and prospects were materially misleading and lacked a reasonable basis [3]. Group 2: Shareholder Actions - Shareholders who purchased HIMS shares during the class period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of August 25, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [2]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 5, 2023, to June 3, 2025 [2]. - Allegations include that the defendants downplayed inefficiencies arising from the integration and assured investors of their commitment to resolving these issues quickly [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of NEOG during the specified timeframe are encouraged to register for the class action by the deadline of September 16, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its Clover platform and the conversion of Payeezy merchants [1]. Group 1: Allegations Against Fiserv - The complaint alleges that Fiserv forced Payeezy merchants to convert to its Clover platform due to cost issues and problems with the older Payeezy platform [1]. - Clover's revenue growth and gross payment volume (GPV) growth were temporarily inflated by these conversions, masking a slowdown in new merchant business [1]. - A significant number of former Payeezy merchants switched to competing solutions shortly after the conversion due to Clover's high pricing and inadequate customer service [1]. - As a result of losing these merchants, Clover's GPV growth significantly slowed, and its revenue growth became unsustainable [1]. - Fiserv's positive statements during the class period regarding Clover's growth strategies and business prospects were deemed materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from July 24, 2024, to July 22, 2025, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is September 22, 2025, with no cost or obligation to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].